NASDAQ:GNPX - Genprex Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$7.7180 -0.02 (-0.26 %)
(As of 07/16/2018 12:44 PM ET)
Previous Close$7.7375
Today's Range$7.65 - $7.76
52-Week Range$3.84 - $19.45
Volume2,046 shs
Average Volume51,950 shs
Market Capitalization$101.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. Genprex, Inc. was founded in 2009 and is based in Austin, Texas.

Receive GNPX News and Ratings via Email

Sign-up to receive the latest news and ratings for GNPX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:GNPX
CUSIPN/A
Phone512-370-4081

Debt

Debt-to-Equity RatioN/A
Current Ratio0.04
Quick Ratio0.04

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees5
Outstanding Shares13,070,000
Market Cap$101.11

The Truth About Cryptocurrencies

Genprex (NASDAQ:GNPX) Frequently Asked Questions

What is Genprex's stock symbol?

Genprex trades on the NASDAQ under the ticker symbol "GNPX."

What is the consensus analysts' recommendation for Genprex?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genprex in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of Genprex's key competitors?

Who are Genprex's key executives?

Genprex's management team includes the folowing people:
  • Mr. John Rodney Varner, Co-Founder, CEO, Sec. & Chairman (Age 61)
  • Dr. Julien L. Pham M.D., MPH, Pres & COO (Age 41)
  • Mr. Ryan M. Confer, Chief Financial Officer (Age 36)
  • Elizabeth Han J.D., Corp. Counsel
  • Dr. Jack A. Roth FACS, M.D., Chairman of Scientific & Medical Advisory Board

When does the company's lock-up period expire?

Genprex's lock-up period expires on Tuesday, September 25th. Genprex had issued 1,280,000 shares in its public offering on March 29th. The total size of the offering was $6,400,000 based on an initial share price of $5.00. After the expiration of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Has Genprex been receiving favorable news coverage?

Headlines about GNPX stock have trended somewhat negative recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Genprex earned a daily sentiment score of -0.05 on Accern's scale. They also gave news stories about the company an impact score of 46.74 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are Genprex's major shareholders?

Genprex's stock is owned by a variety of of retail and institutional investors. Top institutional investors include TEXAS TREASURY SAFEKEEPING TRUST COMPANY (9.48%). Company insiders that own Genprex stock include Jack A Roth and John Rodney Varner. View Institutional Ownership Trends for Genprex.

How do I buy shares of Genprex?

Shares of GNPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genprex's stock price today?

One share of GNPX stock can currently be purchased for approximately $7.7180.

How big of a company is Genprex?

Genprex has a market capitalization of $101.11 million. Genprex employs 5 workers across the globe.

How can I contact Genprex?

Genprex's mailing address is 1701 Trinity Street Suite 3.322, AUSTIN TX, 78705. The company can be reached via phone at 512-370-4081 or via email at [email protected]


MarketBeat Community Rating for Genprex (NASDAQ GNPX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  16 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about Genprex and other stocks. Vote "Outperform" if you believe GNPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.